ONE-WAYOngoing theme · still written in the latest filings
Progression of Multiple Clinical Development Candidates and Expansion of Approvals and Commercial Launches
A theme focused on advancing clinical development candidates such as Enhertu and Datroway through additional approvals, launches in the US and Europe, and commercialization, following Phase 3 trials in multiple regions and FDA Breakthrough Therapy designation.
Companies9How many companies write about this.
Threads11One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhelps11 helps · 0 hurts · 0 flat